FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043160793> ?p ?o ?g. }

• W3043160793 endingPage "107307" @default.
• W3043160793 startingPage "107307" @default.
• W3043160793 abstract "Objective Seizures often occur in patients with primary brain tumor (BT). The aim of this study was to determine if there is an association between the time of occurrence of seizures during the course of BT and survival of these patients. Methods This retrospective cohort study at Henry Ford Hospital, an urban tertiary referral center, included all patients who were diagnosed with primary BTs at Henry Ford Health System between January 2006 and December 2014. Timing of seizure occurrence, if occurred at presentation or after the tumor diagnosis during follow-up period, in different grades of BTs, and survival of these patients were analyzed. Results Of the 901 identified patients, 662 (53% male; mean age: 56 years) were included in final analysis, and seizures occurred in 283 patients (43%). Patients with World Health Organization (WHO) grade III BT with seizures as a presenting symptom only had better survival (adjusted hazard ratio (HR): 0.27; 95% confidence interval (CI), 0.11–0.67; P = 0.004). Seizures that occurred after tumor diagnosis only (adjusted HR: 2.11; 95% CI, 1.59–2.81; P < 0.001) in patients with WHO grade II tumors (adjusted HR: 3.41; 95% CI, 1.05–11.1; P = 0.041) and WHO grade IV tumors (adjusted HR: 2.14; 95% CI, 1.58–2.90; P < 0.001) had higher mortality. Seizures that occurred at presentation and after diagnosis also had higher mortality (adjusted HR: 1.34; 95% CI, 1.00–1.80; P = 0.049), in patients with meningioma (adjusted HR: 6.19; 95% CI, 1.30–29.4; P = 0.021) and grade III tumors (adjusted HR: 6.19; 95% CI, 2.56–15.0; P < 0.001). Conclusion Seizures occurred in almost half of the patients with BTs. The association between seizures in patients with BT and their survival depends on the time of occurrence of seizures, if occurring at presentation or after tumor diagnosis, and the type of tumor. Better survival was noted in patients with WHO grade III BTs who had seizures at presentation at the time of diagnosis, while higher mortality was noted in WHO grade II tumors who had seizure at presentation and after tumor diagnosis, and in grade IV tumors after tumor diagnosis." @default.
• W3043160793 created "2020-07-23" @default.
• W3043160793 creator A5023517393 @default.
• W3043160793 creator A5025864588 @default.
• W3043160793 creator A5025957323 @default.
• W3043160793 creator A5026869480 @default.
• W3043160793 creator A5035387252 @default.
• W3043160793 creator A5045918675 @default.
• W3043160793 creator A5050782605 @default.
• W3043160793 creator A5062960565 @default.
• W3043160793 creator A5070637070 @default.
• W3043160793 creator A5070827831 @default.
• W3043160793 creator A5075268079 @default.
• W3043160793 date "2020-10-01" @default.
• W3043160793 modified "2023-10-14" @default.
• W3043160793 title "Effect of seizure timing on long-term survival in patients with brain tumor" @default.
• W3043160793 cites W1497406013 @default.
• W3043160793 cites W1608734166 @default.
• W3043160793 cites W1976686352 @default.
• W3043160793 cites W1980040802 @default.
• W3043160793 cites W1997208419 @default.
• W3043160793 cites W2003107243 @default.
• W3043160793 cites W2009879287 @default.
• W3043160793 cites W2015288103 @default.
• W3043160793 cites W2055166012 @default.
• W3043160793 cites W2065018463 @default.
• W3043160793 cites W2080279734 @default.
• W3043160793 cites W2097722582 @default.
• W3043160793 cites W2111042597 @default.
• W3043160793 cites W2113460821 @default.
• W3043160793 cites W2125360780 @default.
• W3043160793 cites W2141485400 @default.
• W3043160793 cites W2187666566 @default.
• W3043160793 cites W2247462887 @default.
• W3043160793 cites W2300775334 @default.
• W3043160793 cites W2366536035 @default.
• W3043160793 cites W2562695356 @default.
• W3043160793 cites W2605860968 @default.
• W3043160793 cites W3022423927 @default.
• W3043160793 doi "https://doi.org/10.1016/j.yebeh.2020.107307" @default.
• W3043160793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32693378" @default.
• W3043160793 hasPublicationYear "2020" @default.
• W3043160793 type Work @default.
• W3043160793 sameAs 3043160793 @default.
• W3043160793 citedByCount "7" @default.
• W3043160793 countsByYear W30431607932021 @default.
• W3043160793 countsByYear W30431607932022 @default.
• W3043160793 countsByYear W30431607932023 @default.
• W3043160793 crossrefType "journal-article" @default.
• W3043160793 hasAuthorship W3043160793A5023517393 @default.
• W3043160793 hasAuthorship W3043160793A5025864588 @default.
• W3043160793 hasAuthorship W3043160793A5025957323 @default.
• W3043160793 hasAuthorship W3043160793A5026869480 @default.
• W3043160793 hasAuthorship W3043160793A5035387252 @default.
• W3043160793 hasAuthorship W3043160793A5045918675 @default.
• W3043160793 hasAuthorship W3043160793A5050782605 @default.
• W3043160793 hasAuthorship W3043160793A5062960565 @default.
• W3043160793 hasAuthorship W3043160793A5070637070 @default.
• W3043160793 hasAuthorship W3043160793A5070827831 @default.
• W3043160793 hasAuthorship W3043160793A5075268079 @default.
• W3043160793 hasConcept C118552586 @default.
• W3043160793 hasConcept C126322002 @default.
• W3043160793 hasConcept C141071460 @default.
• W3043160793 hasConcept C167135981 @default.
• W3043160793 hasConcept C187212893 @default.
• W3043160793 hasConcept C207103383 @default.
• W3043160793 hasConcept C2778186239 @default.
• W3043160793 hasConcept C2779160599 @default.
• W3043160793 hasConcept C2780283434 @default.
• W3043160793 hasConcept C44249647 @default.
• W3043160793 hasConcept C71924100 @default.
• W3043160793 hasConcept C72563966 @default.
• W3043160793 hasConceptScore W3043160793C118552586 @default.
• W3043160793 hasConceptScore W3043160793C126322002 @default.
• W3043160793 hasConceptScore W3043160793C141071460 @default.
• W3043160793 hasConceptScore W3043160793C167135981 @default.
• W3043160793 hasConceptScore W3043160793C187212893 @default.
• W3043160793 hasConceptScore W3043160793C207103383 @default.
• W3043160793 hasConceptScore W3043160793C2778186239 @default.
• W3043160793 hasConceptScore W3043160793C2779160599 @default.
• W3043160793 hasConceptScore W3043160793C2780283434 @default.
• W3043160793 hasConceptScore W3043160793C44249647 @default.
• W3043160793 hasConceptScore W3043160793C71924100 @default.
• W3043160793 hasConceptScore W3043160793C72563966 @default.
• W3043160793 hasFunder F4320309659 @default.
• W3043160793 hasLocation W30431607931 @default.
• W3043160793 hasOpenAccess W3043160793 @default.
• W3043160793 hasPrimaryLocation W30431607931 @default.
• W3043160793 hasRelatedWork W2003938723 @default.
• W3043160793 hasRelatedWork W2035277224 @default.
• W3043160793 hasRelatedWork W2047967234 @default.
• W3043160793 hasRelatedWork W2118496982 @default.
• W3043160793 hasRelatedWork W2166867133 @default.
• W3043160793 hasRelatedWork W2439875401 @default.
• W3043160793 hasRelatedWork W2890039708 @default.
• W3043160793 hasRelatedWork W4238867864 @default.
• W3043160793 hasRelatedWork W4384497977 @default.
• W3043160793 hasRelatedWork W2525756941 @default.

• next